Lovells

Lovells advised ABN AMRO and Sal. Oppenheim in relation to The Carlyle Group's offer to acquire Athens listed chemical company Neochimiki L.V. Lavrentiadis S.A. valued at approximately €749 million.  The mandatory offer was announced on 29 May.  

Neochimiki L.V. Lavrentiadis is a leading chemical company in South Eastern Europe and specialises in the production, blending, packaging and distribution of chemicals.  Lovells advised global banking group ABN AMRO in its capacity as financial advisor, and private bank Sal. Oppenheim as broker on the deal. 

The Lovells' team was led by corporate partners Maegen Morrison and Richard Brown in London with assistance from corporate associate Ilona Pynne and by acquisition finance partner Penny Angell in London with assistance from of counsel Andrew Spence.  

Maegen Morrison said:

"This was a great deal for Lovells to represent ABN AMRO and Sal. Oppenheim.  It was a complex cross border deal which threw up a number of novel structural and funding issues that needed to be dealt with.  This deal shows that there is still an appetite out there for the right acquisitions."

Richard Brown said:

"It has been a pleasure working with ABN AMRO and Sal. Oppenheim on this deal. This deal reflects Lovells' strategic focus on advising leading investment banks on high end equity capital markets and corporate M&A work. We hope to see further opportunities for us in this area as our global clients seek to adopt an international style of project management in cross border deals."